Web News Insider
-
E. coli Outbreak Hits 75 Cases in McDonald’s Quarter Pounders
The E. coli outbreak tied to McDonald’s Quarter Pounder hamburgers now stands at 75 confirmed cases as of October 25, 2024. That…
-
FDA Approves Genentech’s Inavolisib for PIK3CA-Mutated Advanced Breast Cancer
On 15 October 2024, the U.S. Food and Drug Administration granted market authorization to Inavolisib, a novel therapy from Genentech, a Roche…
-
Dana-Farber Retracts and Corrects Dozens of Papers, Then CEO Laurie Glimcher Steps Down
BOSTON, USA — Dana-Farber Cancer Institute is facing a leadership crisis and a wave of scientific corrections after an investigation uncovered research…
-
How the GLP-1 Hormone Works and Why It Became a Diabetes and Obesity Drug Target
A hormone first characterized in the 1980s has become the foundation of a major transformation in how physicians manage diabetes and obesity.…
-
Rwanda’s Marburg Outbreak in Kigali Kills 13, Infects 58
Just four weeks ago, Rwanda had no history of Marburg virus disease. Today, the nation is confronting its first outbreak, with 58…
-
Rwanda Reports First Marburg Virus Outbreak
The World Health Organization (WHO) has been informed of the first-ever outbreak of Marburg virus disease (MVD) in Rwanda, as reported on…
-
England’s Junior Doctors Accept 22% Pay Deal, Ending 18-Month NHS Dispute
United Kingdom, September 18, 2024 — cybernewschronicle.com — The 2022–2024 National Health Service (NHS) strikes were a series of concurrent industrial disputes…
-
FDA Approves New Schizophrenia Medication With Unique Mechanism
The U.S. Food and Drug Administration granted approval on September 15, 2024, for a new fixed-dose combination medication designed to treat schizophrenia.…
-
Pfizer Drug Ponsegromab Boosts Weight in Cachexia Trial
Cancer patients losing dangerous amounts of weight have long had few medical options. A monoclonal antibody called ponsegromab might change that. Pfizer…
-
FDA Approves Lazertinib With Amivantamab as First-Line Treatment for EGFR Lung Cancer
For patients with a common form of lung cancer, a new treatment option arrived in the United States on August 15, 2024.…
-
Gabon Confirms First Mpox Case in Man Who Returned From Uganda
Health authorities in Gabon announced on August 23 that a man who arrived by air from Uganda has tested positive for mpox.…
-
FDA Approves Voranigo, a Daily Pill That Delays Progression of Low-Grade Glioma
Each year, about 1,500 Americans receive a diagnosis of grade 2 glioma, a slowly progressing yet aggressive brain tumor. Until now, treatment…
-
MAHA Push Is Changing How Americans Snack, NIQ Data Shows
WASHINGTON, D.C. — The slogan “Make America Healthy Again” is not new. Its roots stretch back decades through the public-health work of…
-
EU Approves New Lymphoma Treatment Odronextamab for Patients
European patients with two forms of lymphoma now have access to a newly approved medication that works through a distinctive biological mechanism.…
-
FDA Approves Yuhan’s Lazertinib, First Korean-Developed Cancer Drug to Win Approval
South Korea, August 16, 2024 — cyberinktimes.com — Almost four years after South Korean regulators gave it the green light, Lazertinib has…
-
Lazertinib Approved in US for Non-Small Cell Lung Cancer Treatment
In August 2024, the U.S. Food and Drug Administration granted approval for lazertinib, expanding the therapeutic arsenal against non‑small cell lung cancer…
-
WHO Declares Mpox a Global Health Emergency for the Second Time as Virus Surges in Africa
Since September 2023, Central Africa has recorded more than 29,000 cases of mpox, with the death toll surpassing 800. The fatality ratio…
-
Deli Meat Outbreak in US Claims Lives and Sparks Safety Concerns
A listeriosis outbreak tied to Boar’s Head Provision Company deli meats has led to at least 10 fatalities and 60 hospitalizations across…
-
Gaza Records First Polio Case in 25 Years as UN Presses for Vaccination Pause
Gaza, July 23, 2024 — infopulsetoday.com — The Gaza Strip’s declaration of a polio epidemic on July 16, 2024, did not happen…
-
FDA Approves Eli Lilly Alzheimer’s Drug Kisunla Amid Safety Concerns
July 18, 2024 — infopulsetoday.com — The path to the FDA’s July 15 approval of donanemab was paved with controversy, clinical risk,…
-
FDA Approves Eli Lilly’s Donanemab for Early Symptomatic Alzheimer Disease
On July 15, 2024, the US Food and Drug Administration (FDA) approved donanemab, a monoclonal antibody developed by Eli Lilly and Company,…
-
Gaza Confirms First Polio Case in 25 Years After Virus Found in Sewage
In the summer of 2024, an unexpected health crisis unfolded in the Gaza Strip, marking a grim resurgence of polio – a…
-
Gaza Declares Polio Epidemic After Virus Found in Sewage, 25 Years After Eradication
The 2024 Gaza Strip polio epidemic, an outbreak of circulating vaccine-derived poliovirus type 2 (cVDPV2), was first discovered on July 16, 2024,…
-
Northwestern and Brigham Scientists Identify Immune Defect in Lupus and a Possible Way to Reverse It
On July 10, 2024, a joint research team from Northwestern University Feinberg School of Medicine and Harvard Medical School released a study…
Most read
-
First Human Data on ER-100: What the Sinclair-Linked Eye Gene Therapy Actually Showed
-
AACR Report Details Rapid Progress in Targeted Cancer Therapies and Survival
-
Study Links High Sugar Intake to 28% Higher Breast Cancer Risk in Korean Women
-
How Satri-Cel Became the World’s First Approved Solid Tumor CAR-T
-
Dexcom CONNECT Study Shows CGM Lowers A1C by 1.6% in Non-Insulin Type 2 Diabetes
-
Missed NHS England cancer‑treatment target threatens bladder‑cancer surgery waiting times
-
AstraZeneca’s Imfinzi Wins FDA Approval for Bladder Cancer Patients
-
How Kazia’s Nuclear PD-L1 Degrader Aims to Overcome Cancer Resistance
-
FDA RMAT and Fast Track Designations Set New Evidence Bar for Cell Therapies
-
How mRNA Technology Is Transforming the Future of Personalized Cancer Vaccines
-
Workers Can Boost Tax Savings by Maximizing New $3,500 Health FSA Limit for 2027
-
Fidelity’s Shift to Managed Accounts and Private Assets: What It Means for 401(k) Savers
-
How Required Minimum Distributions Work and Strategies to Lower Taxes
-
How the 2027 401(k) Limit Increase to $25,500 Changes Retirement Planning
-
BMS GPRC5D CAR-T Arlo-cel Shows Deep Responses After BCMA Failure
-
Understanding the FDA’s Accelerated Approval of Iberdomide for Multiple Myeloma
-
Rockefeller’s 2141-V11 Trial Shows Complete Remission in Two Metastatic Cancer Patients
-
Ellie Sullivan: Genetic Testing Refused for a Decade, Then Offered After Her Diagnosis
-
Personalized mRNA Cancer Vaccine Succeeds in First Phase 3 Melanoma Trial
-
Indiana University Study Ties Delayed Colorectal Cancer Treatment to Higher Metastasis Risk
-
Study: People Who Drank More Water With Meals Ate More Food, Not Less
-
Why Mornings Are Hardest With ADHD: Late Body Clocks, Poor Sleep and Dopamine
-
Immunotherapy and Genome-Based Vaccines Put the Immune System to Work Against Disease
-
Geneticist John Hardy Proposed Alzheimer’s Amyloid Hypothesis in 1992